Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
Use this ACLX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ACLX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ACLX SEC filings page. Lician reads the product cache first so this HTML stays unique to Arcellx Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ACLX income, balance, and cash tables.